161 related articles for article (PubMed ID: 33380651)
1. Eyelid carcinoma: An experience from a tertiary cancer center.
Thiagarajan S; Bahani A; Chaukar D; Dcruz AK
J Cancer Res Ther; 2020 Dec; 16(Supplement):S48-S52. PubMed ID: 33380651
[TBL] [Abstract][Full Text] [Related]
2. Patterns of lymphatic spread and the management of eyelid carcinomas.
Hashimoto K; Yasumatsu R; Toh S; Shiratsuchi H; Yoshida T; Nishiyama K; Yoshikawa H; Nakashima T; Nakagawa T
Auris Nasus Larynx; 2016 Dec; 43(6):666-71. PubMed ID: 26965587
[TBL] [Abstract][Full Text] [Related]
3. Impact of clinicopathologic factors on survival in patients with sebaceous carcinoma of the eyelid - a population-based analysis.
Lee IJ; Koh JY
Orbit; 2019 Aug; 38(4):261-268. PubMed ID: 30373440
[No Abstract] [Full Text] [Related]
4. Periocular skin cancer: Diagnosis and management.
Moran JM; Phelps PO
Dis Mon; 2020 Oct; 66(10):101046. PubMed ID: 32600650
[TBL] [Abstract][Full Text] [Related]
5. Treatment and outcomes for metastatic sebaceous cell carcinoma of the eyelid.
Husain A; Blumenschein G; Esmaeli B
Int J Dermatol; 2008 Mar; 47(3):276-9. PubMed ID: 18289332
[TBL] [Abstract][Full Text] [Related]
6. Eyelid sebaceous carcinoma: Validation of the 8th edition of the American Joint Committee on cancer T staging system and the prognostic factors for local recurrence, nodal metastasis, and survival.
Hsia Y; Yeh CY; Wei YH; Chen LW; Liao SL
Eye (Lond); 2019 Jun; 33(6):887-895. PubMed ID: 31147618
[TBL] [Abstract][Full Text] [Related]
7. Prognostic factors for local recurrence, metastasis and survival for sebaceous carcinoma of the eyelid: observations in 100 patients.
Sa HS; Rubin ML; Xu S; Ning J; Tetzlaff M; Sagiv O; Kandl TJ; Esmaeli B
Br J Ophthalmol; 2019 Jul; 103(7):980-984. PubMed ID: 30131380
[TBL] [Abstract][Full Text] [Related]
8. 14-year case series of eyelid sebaceous gland carcinoma in Chinese patients and review of management.
Lam SC; Li EYM; Yuen HKL
Br J Ophthalmol; 2018 Dec; 102(12):1723-1727. PubMed ID: 29459429
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of eyelid sebaceous gland carcinoma based on the tumor (T) category of the American Joint Committee on Cancer (AJCC) classification.
Kaliki S; Gupta A; Ali MH; Ayyar A; Naik MN
Int Ophthalmol; 2016 Oct; 36(5):681-90. PubMed ID: 26830096
[TBL] [Abstract][Full Text] [Related]
10. American Joint Committee on Cancer T category for eyelid sebaceous carcinoma correlates with nodal metastasis and survival.
Esmaeli B; Nasser QJ; Cruz H; Fellman M; Warneke CL; Ivan D
Ophthalmology; 2012 May; 119(5):1078-82. PubMed ID: 22330966
[TBL] [Abstract][Full Text] [Related]
11. Sebaceous carcinoma of the eyelids: personal experience with 60 cases.
Shields JA; Demirci H; Marr BP; Eagle RC; Shields CL
Ophthalmology; 2004 Dec; 111(12):2151-7. PubMed ID: 15582067
[TBL] [Abstract][Full Text] [Related]
12. Sebaceous carcinoma.
Nelson BR; Hamlet KR; Gillard M; Railan D; Johnson TM
J Am Acad Dermatol; 1995 Jul; 33(1):1-15; quiz 16-8. PubMed ID: 7601925
[TBL] [Abstract][Full Text] [Related]
13. Malignant eyelid tumours in Taiwan.
Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
[TBL] [Abstract][Full Text] [Related]
14. Collision tumor of sebaceous carcinoma and squamous cell carcinoma of the eyelid: Case report.
Wang JJ; Lee KF; Chen CY
Eur J Ophthalmol; 2022 Sep; 32(5):NP55-NP59. PubMed ID: 34011202
[TBL] [Abstract][Full Text] [Related]
15. Validation Study of the AJCC Cancer Staging Manual, Eighth Edition, Staging System for Eyelid and Periocular Squamous Cell Carcinoma.
Xu S; Sagiv O; Rubin ML; Sa HS; Tetzlaff MT; Nagarajan P; Ning J; Esmaeli B
JAMA Ophthalmol; 2019 May; 137(5):537-542. PubMed ID: 30869769
[TBL] [Abstract][Full Text] [Related]
16. Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function.
Hata M; Koike I; Maegawa J; Kaneko A; Odagiri K; Kasuya T; Minagawa Y; Kaizu H; Mukai Y; Inoue T
Strahlenther Onkol; 2012 Dec; 188(12):1102-7. PubMed ID: 23104519
[TBL] [Abstract][Full Text] [Related]
17. Sebaceous carcinoma of the eyelid: 21-year experience in a Nordic country.
Niinimäki P; Siuko M; Tynninen O; Kivelä TT; Uusitalo M
Acta Ophthalmol; 2021 Mar; 99(2):181-186. PubMed ID: 32749765
[TBL] [Abstract][Full Text] [Related]
18. Androgen receptor identification in the diagnosis of eyelid sebaceous carcinomas.
Jakobiec FA; Werdich X
Am J Ophthalmol; 2014 Mar; 157(3):687-96.e1-2. PubMed ID: 24333189
[TBL] [Abstract][Full Text] [Related]
19. Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma.
Leivo T; Sarmela J; Enckell-Aaltonen M; Dafgård Kopp E; Schmitt C; Toft PB; Sigurdsson H; Uusitalo M
BMC Ophthalmol; 2020 Mar; 20(1):103. PubMed ID: 32178641
[TBL] [Abstract][Full Text] [Related]
20. Sebaceous carcinoma of the eyelid: a clinicopathological study.
Zürcher M; Hintschich CR; Garner A; Bunce C; Collin JR
Br J Ophthalmol; 1998 Sep; 82(9):1049-55. PubMed ID: 9893597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
